April 12, 2018
Poster presentation of preliminary data from the ongoing extension period of the Phase 2 trial with WTX101 presented at the EASL meeting
March 12, 2018
Wilson Therapeutics at Cowen & Company 38th Annual Healthcare Conference
March 6, 2018
Wilson Therapeutics at Stockholm Corporate Finance Life Science Seminar (Swedish)
November 14, 2017
Wilson Therapeutics at Stora Aktiedagen Stockholm (Swedish)
October 25, 2017
Presentation of preliminary data from the ongoing extension period of the Phase 2 trial with WTX101 by Professor Michael L. Schilsky. Recording of webcast hosted by DNB.
August 28, 2017
Presentation of current treatments for Wilson Disease with a focus on novel treatment perspectives
April 24, 2017
Presentation of final Phase 2 data from the Phase 2 trial with WTX101 with Professor Karl Heinz Weiss. Recording of presentation held at the EASL meeting.